ArticleThoracic cancer2020

Immunotherapy as second-line treatment and beyond for non-small cell lung cancer in a single center of China: Outcomes, toxicities, and clinical predictive factors from a real-world retrospective analysis.

Minjiang Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.